logo
搜索
菜单

Concentrat的搜索结果

当前1/17页
排序: 最近更新
7.1: Tensile Strength Considerations of Concrete 01:16 min
7.1: Tensile Strength Considerations of Concrete
MRI-guided Disruption of the Blood-brain Barrier using Transcranial Focused Ultrasound in a Rat Model 10.3791/3555-v 07:42 min
MRI-guided Disruption of the Blood-brain Barrier using Transcranial Focused Ultrasound in a Rat Model
Measurement of Cytosolic Ca2+ in Isolated Contractile Lymphatics 10.3791/3438-v 08:08 min
Measurement of Cytosolic Ca2+ in Isolated Contractile Lymphatics
8.11: Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding 01:22 min
8.11: Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding
8.5: Nonlinear Pharmacokinetics: Drug Elimination for IV Bolus Injection 00:59 min
8.5: Nonlinear Pharmacokinetics: Drug Elimination for IV Bolus Injection
8.4: Determination of Michaelis Constant and Maximum Elimination Rate 01:20 min
8.4: Determination of Michaelis Constant and Maximum Elimination Rate
8.3: Nonlinear Pharmacokinetics: Michaelis-Menten Equation 01:18 min
8.3: Nonlinear Pharmacokinetics: Michaelis-Menten Equation
Determining the Contribution of the Energy Systems During Exercise 10.3791/3413-v
Determining the Contribution of the Energy Systems During Exercise
8.1: Nonlinear Pharmacokinetics: Overview 01:19 min
8.1: Nonlinear Pharmacokinetics: Overview
7.27: Noncompartmental Analysis: Mean Residence Time 01:05 min
7.27: Noncompartmental Analysis: Mean Residence Time
7.26: Noncompartmental Analysis: Statistical Moment Theory 00:56 min
7.26: Noncompartmental Analysis: Statistical Moment Theory
7.25: Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis 00:59 min
7.25: Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
7.24: Model Approaches for Pharmacokinetic Data: Distributed Parameter Models 01:06 min
7.24: Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
7.23: Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance 01:07 min
7.23: Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
7.22: Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models 00:57 min
7.22: Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models
7.21: Physiological Pharmacokinetic Models: Assumption with Protein Binding 01:13 min
7.21: Physiological Pharmacokinetic Models: Assumption with Protein Binding
7.18: Mechanistic Models: Compartment Models in Individual and Population Analysis 01:23 min
7.18: Mechanistic Models: Compartment Models in Individual and Population Analysis
In vitro Uncoating of HIV-1 Cores 10.3791/3384-v 10:49 min
In vitro Uncoating of HIV-1 Cores
7.16: Three-Compartment Open Model 01:06 min
7.16: Three-Compartment Open Model
7.15: Two-Compartment Open Model: Extravascular Administration 01:12 min
7.15: Two-Compartment Open Model: Extravascular Administration
返回顶部